SCHEMBL968991

SCHEMBL968991

C=CCN1CCN(C(=O)CN2CCc3c([nH]c4ccccc34)C2)CC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.61
KDM4E B2RXH2 2/20 0.61
HPGD P15428 1/20 0.61
GPX4 P36969 1/20 0.54
MAPT P10636 2/20 0.52
GAA P10253 1/20 0.52
GRIN2B Q13224 1/20 0.50
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
HDAC1 Q13547 4/20 0.49
HDAC6 Q9UBN7 4/20 0.49
HDAC3 O15379 1/20 0.48
HDAC4 P56524 1/20 0.48
HDAC7 Q8WUI4 1/20 0.48
HDAC2 Q92769 1/20 0.48
HDAC10 Q969S8 1/20 0.48
HDAC11 Q96DB2 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
HDAC9 Q9UKV0 1/20 0.48
HDAC5 Q9UQL6 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL969403 0.86 ALDH1A1 (0.64) ALDH1A1KDM4EHPGDGPX4MAPT
SCHEMBL969099 0.85 ALDH1A1 (0.69) ALDH1A1KDM4EHPGDGPX4MAPT
SCHEMBL967406 0.84 ALDH1A1 (0.62) ALDH1A1KDM4EHPGDGPX4MAPT
SCHEMBL967323 0.84 ALDH1A1 (0.71) ALDH1A1KDM4EHPGDGPX4MAPT
SCHEMBL969021 0.84 ALDH1A1 (0.62) ALDH1A1KDM4EHPGDGPX4MAPT
SCHEMBL969372 0.83 KDM4E (0.67) ALDH1A1KDM4EHPGDGPX4MAPT
SCHEMBL967361 0.83 ALDH1A1 (0.63) ALDH1A1KDM4EHPGDGPX4MAPT
SCHEMBL968842 0.82 KDM4E (0.69) ALDH1A1KDM4EHPGDGPX4MAPT
SCHEMBL968675 0.82 HTR1A (0.66) ALDH1A1KDM4EHPGDGPX4MAPT
SCHEMBL970324 0.81 ALDH1A1 (0.64) ALDH1A1KDM4EHPGDGPX4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US claimed
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US disclosed
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US disclosed
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US disclosed
WO-2009003003-A2 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2008-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES HRH3, HRH4, HRH1 ALDH1A1 812/4885KDM4E 3037/4885HPGD 606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.